Sato Vicki L

DirectorVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$413K
Net Open-Market Flow
-$413K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Option exercise(M)42K$1.49$63K1.2M
Feb 24, 2026Sell(S)42K$9.75$411K1.1M
Feb 24, 2026Sell(S)200$10.26$2K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2026Option exercise(M)42K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-012397) within minutes of acceptance. Every field above traces to the original document. Verify it directly: